Andy Bader, PhD

Entrepreneur in Residence, Accelerator for Cancer Therapeutics

Andy Bader Final Choice

Dr. Andreas (Andy) Bader joined TMC Innovation as an Entrepreneur-In-Residence in 2025, bringing more than 25 years of experience in oncology drug discovery, development, and strategic leadership. A seasoned biotech executive, Dr. Bader held leadership roles in early-stage startups and established biotech organizations, where he directed R&D strategies to advance multiple first-in-class therapies from discovery to clinical trials, built high-performing teams, and helped raise funds via venture capital, IPO, and government grants to advance therapeutic innovation. He completed his postdoctoral training at The Scripps Research Institute in La Jolla, California, holds a PhD in Biochemistry, and earned an MSc in Microbiology & Immunology from the University of Innsbruck, Austria. At TMC Innovation, Dr. Bader leverages his expertise to mentor emerging biotech ventures, catalyzing transformative solutions in healthcare.

Back to top